Even Partial Antenatal Steroid Treatment Benefits Preemies

Share this content:
Even Partial Antenatal Steroid Treatment Benefits Preemies
Even Partial Antenatal Steroid Treatment Benefits Preemies

MONDAY, Oct. 10, 2016 (HealthDay News) -- Even partial steroid treatment before birth can improve survival odds for extremely premature infants and reduce their risk of certain birth defects, according to a study published online Oct. 10 in JAMA Pediatrics.

The investigators analyzed data from 6,121 extremely premature infants who were born between 22 and 27 weeks of pregnancy. They were followed for 18 to 22 months after birth. Their mothers received either complete, partial, or no steroid treatment.

The researchers observed significant differences among the three groups of infants in mortality rates and complications such as severe intracranial hemorrhage, necrotizing enterocolitis, bronchopulmonary dysplasia, and neurodevelopmental impairment. These rates were lowest among infants in the complete steroid treatment group, but those in the partial treatment group had better outcomes than those in the untreated group.

"Antenatal steroid exposure was associated with a dose-dependent protective effect against death or neurodevelopmental impairment in extremely preterm infants. The effect was partly mediated by antenatal steroid-associated reductions in rates of severe intracranial hemorrhage and/or cystic periventricular leukomalacia," the authors write. "These results support prompt administration of antenatal steroids, with the goal of a complete course prior to delivery."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »